| Baselga J
Novel agents in the era of targeted therapy: what have we learned and how has our practice changed? [Journal Article]
Ann Oncol 2008 Sep.:vii281-8.
Full Citation | Publisher Full Text | Find Related Articles |
| Hatake K, Tokudome N, Ito Y
Next Generation Molecular Targeted Agents for Breast Cancer: Focus on EGFR and VEGFR Pathways. [Journal Article]
Breast Cancer 2007; 14(2):132-49.
Abstract | Full Citation | Find Related Articles |
| Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG
ErbB/HER receptor family in breast cancer--the more we search the more we learn. [JOURNAL ARTICLE]
Ann Oncol 2008 Mar 19.
Full Citation | Publisher Full Text | Find Related Articles |
| Gaguski ME
Targeted therapies: aiming for the bull's-eye. [Journal Article]
ONS Connect 2007 Jul; 22(7):8-12.
Full Citation | Find Related Articles |
| Campos SM
Anti-epidermal growth factor receptor strategies for advanced breast cancer. [Journal Article]
Cancer Invest 2008 Oct; 26(8):757-68.
Full Citation |
| Elez E, Macarulla T, Tabernero J
Handling side-effects of targeted therapies: safety of targeted therapies in solid tumours. [Journal Article]
Ann Oncol 2008 Sep.:vii146-52.
Full Citation | Publisher Full Text | Find Related Articles |
| Black JD, Brattain MG, Krishnamurthi SA, et al.
ErbB family targeting. [Journal Article, Review]
Curr Opin Investig Drugs 2003 Dec; 4(12):1451-4.
Abstract | Full Citation | Find Related Articles |
| Dassonville O, Bozec A, Fischel JL, et al.
EGFR targeting therapies: Monoclonal antibodies versus tyrosine kinase inhibitors Similarities and differences. [JOURNAL ARTICLE]
Crit Rev Oncol Hematol 2007 Feb 24.
Abstract | Full Citation | Find Related Articles |
| Gallick GE
SRC as a potential therapeutic target in solid tumor oncology. [Journal Article]
Clin Adv Hematol Oncol 2004 Jul; 2(7):435-7.
Full Citation | Find Related Articles |
  |
